InsidersTradesSigma
Follow the 安科生物 share price and the full management transaction log of the company, a listed issuer based in China. Shares trade on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 安科生物 has published 3 public disclosures. Market capitalisation: €13.8bn. The latest transaction was reported on 30 May 2023 (Purchase). Among the most active insiders: 周源源. The full history is free.
3
Insider Decl.
n/a
Thresholds
€374,633
2 ops.
Buy Volume
€338,545
1 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 3,175 of 28,932 companies
72.9
score / 100
Value58
Quality88
FCF yld5.3%
Earn yld5.3%
EV/EBITDA14.4x
ROE15%
Gross mgn76%
Net mgn28%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 30 May 2023
About 安科生物
安科生物 is a company focused on the healthcare and pharmaceutical sector, specializing in the development of biopharmaceutical products. It is listed on the XSHE market.